Literature DB >> 12097455

Dual time point 18F-FDG PET for the evaluation of pulmonary nodules.

Alexander Matthies1, Marc Hickeson, Andrew Cuchiara, Abass Alavi.   

Abstract

UNLABELLED: 18F-FDG PET has reached widespread application in the assessment of pulmonary nodules. This study compares the diagnostic accuracy of standard 18F-FDG PET scanning with those of dual time point 18F-FDG PET scanning.
METHODS: Thirty-six patients (21 women, 15 men; mean age, 67 y; range, 36-88 y) with 38 known or suspected malignant pulmonary nodules underwent PET of the thorax at 2 time points: scan 1 at 70 min (range, 56-110 min) and scan 2 at 123 min (range, 100-163 min) after the intravenous injection of 2.5 MBq 18F-FDG per kilogram of body weight. All scanning was performed on a dedicated C-PET scanner. The mean interval between the scans was 56 min (range, 49-64 min). Regions of interest were overlaid onto each fully corrected image in the areas of the radiographically known lung densities. The standardized uptake values (SUVs) were calculated for both time points.
RESULTS: Surgical pathology and follow-up revealed 19 patients with 20 malignant tumors, whereas 16 patients had benign lesions. The tumor SUVs (mean +/- SD) were 3.66 +/- 1.95 (scan 1) and 4.43 +/- 2.43 (scan 2) (20.5% +/- 8.1% increase; P < 0.01). Four of 20 malignant tumors had SUVs of <2.5 on scan 1 (range, 1.12-1.69). Benign lesions had SUVs of 1.14 +/- 0.64 (scan 1) and 1.11 +/- 0.70 (scan 2) (P = not significant). Standard PET scanning (single time point) with a threshold SUV of 2.5 (at time point 1) reached a sensitivity of 80% and a specificity of 94%; dual time point scanning with a threshold value of 10% increase between scan 1 and scan 2 reached a sensitivity of 100% with a specificity of 89%.
CONCLUSION: Dual time point 18F-FDG PET results in a very high sensitivity and specificity for detection of malignant lung tumors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12097455

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  83 in total

1.  FDG-PET in infectious and inflammatory disease.

Authors:  Wim J G Oyen; Luigi Mansi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-10-02       Impact factor: 9.236

2.  Use of ¹⁸F-fluorodeoxyglucose positron emission tomography-computed tomography in a miniature pig (Sus scrofa domestica) with pneumonia.

Authors:  Jong-In Kim; Young Ah Lee; Jae Won Lee; Sang Min Jeong; Hyun Woo Chung; Jin Soo Han
Journal:  Comp Med       Date:  2012-06       Impact factor: 0.982

3.  Diagnostic performance and prognostic impact of FDG-PET in suspected recurrence of surgically treated non-small cell lung cancer.

Authors:  Dirk Hellwig; Andreas Gröschel; Thomas P Graeter; Anne P Hellwig; Ursula Nestle; Hans-Joachim Schäfers; Gerhard W Sybrecht; Carl-Martin Kirsch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-09-09       Impact factor: 9.236

4.  Is whole-body FDG-PET valuable for health screening? For.

Authors:  Michiru Ide; Yutaka Suzuki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-03       Impact factor: 9.236

5.  Partial volume correction of standardized uptake values and the dual time point in FDG-PET imaging: should these be routinely employed in assessing patients with cancer?

Authors:  Sandip Basu; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-10       Impact factor: 9.236

Review 6.  The pulmonary nodule: clinical and radiological characteristics affecting a diagnosis of malignancy.

Authors:  L Cardinale; F Ardissone; S Novello; M Busso; F Solitro; M Longo; D Sardo; M Giors; C Fava
Journal:  Radiol Med       Date:  2009-05-29       Impact factor: 3.469

7.  Dual-phase FDG-PET: delayed acquisition improves hepatic detectability of pathological uptake.

Authors:  V Arena; A Skanjeti; R Casoni; A Douroukas; E Pelosi
Journal:  Radiol Med       Date:  2008-07-10       Impact factor: 3.469

8.  Dynamic changes of FDG uptake and clearance in normal tissues.

Authors:  Gang Cheng; Abass Alavi; Esther Lim; Thomas J Werner; Catherine V Del Bello; Scott R Akers
Journal:  Mol Imaging Biol       Date:  2013-06       Impact factor: 3.488

9.  Dual-time-point [18F]-FDG PET/CT in the diagnostic evaluation of suspicious breast lesions.

Authors:  M G Caprio; A Cangiano; M Imbriaco; F Soscia; G Di Martino; A Farina; G Avitabile; L Pace; P Forestieri; M Salvatore
Journal:  Radiol Med       Date:  2009-12-16       Impact factor: 3.469

10.  Usefulness of additional delayed regional F-18 Fluorodeoxy-Glucose Positron Emission Tomography in the lymph node staging of Non-Small Cell Lung Cancer patients.

Authors:  Young So; June-Key Chung; Jae Min Jeong; Dong Soo Lee; Myung Chul Lee
Journal:  Cancer Res Treat       Date:  2005-04-30       Impact factor: 4.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.